Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
Prenatal Diagnosis
|
November 15, 2014
First-trimester combined screening for trisomy 21 in women with renal disease
Morgane Valentin, Françoise Muller, Marie Paule Beaujard, et al.
Prenatal Diagnosis
|
May 13, 2018
Prenatal diagnosis of megacystis microcolon intestinal hypoperistalsis syndrome by biochemical analysis of fetal urine
Jonathan Rosenblatt, Sophie Dreux, Emmanuel Spaggiari, et al.
Prenatal Diagnosis
|
November 9, 2002
Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers
Françoise Muller, Didier Thibaud, Françoise Poloce, et al.
American Journal of Obstetrics and Gynecology
|
February 26, 2004
Nonimmune fetal ascites: a series of 79 cases
Romain Favre, Sophie Dreux, Marc Dommergues, et al.
American Journal of Obstetrics and Gynecology
|
January 15, 2013
Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay
Emmanuel Spaggiari, Marie Ruas, Sophie Dreux, et al.
Prenatal Diagnosis
|
December 24, 2003
Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome
Françoise Muller, Sophie Dreux, Alain Lemeur, et al.
Prenatal Diagnosis
|
May 1, 2012
Outcome of prenatally detected bilateral higher urinary tract obstruction or megacystis: sex-related study on a series of 709 cases
Hamdan Al-Hazmi, Sophie Dreux, Anne-Lise Delezoide, et al.
Prenatal Diagnosis
|
August 14, 2013
Outcome and etiologies of fetal megacystis according to the gestational age at diagnosis
Marie Bornes, Emmanuel Spaggiari, Thomas Schmitz, et al.
Fetal Diagnosis and Therapy
|
March 23, 2021
Evaluation of Sequential Urine Analysis when Selecting Candidates for Vesicoamniotic Shunting in Lower Urinary Tract Obstruction
Antoine Koch, Romain Favre, Anne-Sophie Weingertner, et al.
Annales De Biologie Clinique
|
July 14, 2021
Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening test
Marie Blanquet, Sophie Dreux, Stéphanie Léger, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
Prenatal Diagnosis
|
November 15, 2014
First-trimester combined screening for trisomy 21 in women with renal disease
Morgane Valentin, Françoise Muller, Marie Paule Beaujard, et al.
Prenatal Diagnosis
|
May 13, 2018
Prenatal diagnosis of megacystis microcolon intestinal hypoperistalsis syndrome by biochemical analysis of fetal urine
Jonathan Rosenblatt, Sophie Dreux, Emmanuel Spaggiari, et al.
Prenatal Diagnosis
|
November 9, 2002
Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markers
Françoise Muller, Didier Thibaud, Françoise Poloce, et al.
American Journal of Obstetrics and Gynecology
|
February 26, 2004
Nonimmune fetal ascites: a series of 79 cases
Romain Favre, Sophie Dreux, Marc Dommergues, et al.
American Journal of Obstetrics and Gynecology
|
January 15, 2013
Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay
Emmanuel Spaggiari, Marie Ruas, Sophie Dreux, et al.
Prenatal Diagnosis
|
December 24, 2003
Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome
Françoise Muller, Sophie Dreux, Alain Lemeur, et al.
Prenatal Diagnosis
|
May 1, 2012
Outcome of prenatally detected bilateral higher urinary tract obstruction or megacystis: sex-related study on a series of 709 cases
Hamdan Al-Hazmi, Sophie Dreux, Anne-Lise Delezoide, et al.
Prenatal Diagnosis
|
August 14, 2013
Outcome and etiologies of fetal megacystis according to the gestational age at diagnosis
Marie Bornes, Emmanuel Spaggiari, Thomas Schmitz, et al.
Fetal Diagnosis and Therapy
|
March 23, 2021
Evaluation of Sequential Urine Analysis when Selecting Candidates for Vesicoamniotic Shunting in Lower Urinary Tract Obstruction
Antoine Koch, Romain Favre, Anne-Sophie Weingertner, et al.
Annales De Biologie Clinique
|
July 14, 2021
Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening test
Marie Blanquet, Sophie Dreux, Stéphanie Léger, et al.
Page
of 8